Jefferies Initiates Coverage On SpyGlass Pharma with Buy Rating, Announces Price Target of $62
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Jefferies analyst Dennis Ding initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $62.
Jefferies analyst Dennis Ding initiates coverage on SpyGlass Pharma (NASDAQ:SGP) with a Buy rating and announces Price Target of $62.